NO940131L - Salts of 4-pyrimidinone derivatives for pharmaceutical use - Google Patents

Salts of 4-pyrimidinone derivatives for pharmaceutical use

Info

Publication number
NO940131L
NO940131L NO940131A NO940131A NO940131L NO 940131 L NO940131 L NO 940131L NO 940131 A NO940131 A NO 940131A NO 940131 A NO940131 A NO 940131A NO 940131 L NO940131 L NO 940131L
Authority
NO
Norway
Prior art keywords
salts
pharmaceutical use
pyrimidinone derivatives
derivatives
pyrimidinone
Prior art date
Application number
NO940131A
Other languages
Norwegian (no)
Other versions
NO940131D0 (en
Inventor
Christian Hoornaert
Alexander Eduard Wick
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO940131D0 publication Critical patent/NO940131D0/en
Publication of NO940131L publication Critical patent/NO940131L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Alkanolaminsalter og basiske aminosyresalter av fire pyrimidi-nonderivater som kan foreligge i form av tautornerer med formel (I) , (I') og (I" ). hvori. Rx står for en rettkjedet eller forgrenet (C-C,)alkylgruppe,. Rstår enten for en aryl (C^-Cj) alkylgruppe som eventuelt er substituert på kjernen, eller en heteroaryl(C-C)alkylgruppe som eventuelt er substituert på kjernen, og. Rstår enten for en COOH-gruppe, eller en lH-tetrazol-5-yl-gruppe.Derivatene har terapeutisk anvendelse. Deres fremstilling er beskrevet.Alkanolamine salts and basic amino acid salts of four pyrimidinone derivatives which may be present in the form of tautanes of formula (I), (I ') and (I "). for an aryl (C The derivatives have therapeutic use, their preparation is described.

NO940131A 1993-01-15 1994-01-14 Salts of 4-pyrimidinone derivatives for pharmaceutical use NO940131L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9300340A FR2700543B1 (en) 1993-01-15 1993-01-15 Salts of 4-pyrimidinone derivatives, their preparation and their therapeutic use.

Publications (2)

Publication Number Publication Date
NO940131D0 NO940131D0 (en) 1994-01-14
NO940131L true NO940131L (en) 1994-07-18

Family

ID=9443056

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940131A NO940131L (en) 1993-01-15 1994-01-14 Salts of 4-pyrimidinone derivatives for pharmaceutical use

Country Status (16)

Country Link
EP (1) EP0607077A1 (en)
JP (1) JPH06271548A (en)
KR (1) KR940018365A (en)
CN (1) CN1096783A (en)
AU (1) AU5317694A (en)
CA (1) CA2113491A1 (en)
CZ (1) CZ9494A3 (en)
FI (1) FI940185A (en)
FR (1) FR2700543B1 (en)
HU (1) HUT70193A (en)
IL (1) IL108342A0 (en)
NO (1) NO940131L (en)
NZ (1) NZ250678A (en)
PL (1) PL301900A1 (en)
SK (1) SK4794A3 (en)
ZA (1) ZA94290B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990081093A (en) 1998-04-25 1999-11-15 조생현 Pyrimidinone compound, pharmaceutical composition containing the same, and preparation method thereof
GB0914287D0 (en) * 2009-08-14 2009-09-30 Pci Biotech As Compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672892B1 (en) * 1991-02-20 1994-01-14 Synthelabo DERIVATIVES OF 4-PYRIMIDINONES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.

Also Published As

Publication number Publication date
CA2113491A1 (en) 1994-07-16
HUT70193A (en) 1995-09-28
IL108342A0 (en) 1994-04-12
CZ9494A3 (en) 1994-08-17
FI940185A0 (en) 1994-01-14
CN1096783A (en) 1994-12-28
HU9400108D0 (en) 1994-05-30
NZ250678A (en) 1994-10-26
PL301900A1 (en) 1994-07-25
JPH06271548A (en) 1994-09-27
FR2700543A1 (en) 1994-07-22
FI940185A (en) 1994-07-16
FR2700543B1 (en) 1995-03-17
ZA94290B (en) 1994-08-17
SK4794A3 (en) 1995-01-12
NO940131D0 (en) 1994-01-14
AU5317694A (en) 1994-07-21
EP0607077A1 (en) 1994-07-20
KR940018365A (en) 1994-08-16

Similar Documents

Publication Publication Date Title
CA2379560A1 (en) Purine derivatives inhibitors of tyrosine protein kinase syk
HUP0004559A1 (en) Aminothiazole inhibitors of cyclin dependent kinases, pharmaceutical compositions containing them and their use
NO890723D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3-ALKENYL-1-AZABICYCLO (3.2.0) HEPT2-AND-2-CARBOXYLIC ACID DERIVATIVES.
NO930511D0 (en) ORTO-SUBSTITUTED BENZOYLGUANIDINES, PROCEDURES FOR THE PREPARATION OF THEM, THEIR USE AS DIAGNOSTIC SUMMARY OF MEDICINAL PRODUCTS CONTAINING THEM
NO995006L (en) New connections
CA2030433A1 (en) New isoquinoline- carboxamide amino acid derivatives useful for treatment of viral diseases
NO941611D0 (en) Novel amino acid derivatives, processes for their preparation and pharmaceutical preparations containing these compounds
NO922940L (en) FIVE-JOINT HETEROCYCLIC COMPOUNDS, PROCEDURES FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM
MXPA01004256A (en) N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors.
NO881940D0 (en) 4-AMINOQINOLINE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS.
NO900306L (en) PROCEDURE FOR THE PREPARATION OF NEW PYRAZOLOPYRIDINE COMPOUNDS.
WO1998056761A3 (en) Benzimidazole derivatives
ES2121760T3 (en) PIRAZOLOPYRIDINE COMPOUND AND PROCEDURE FOR ITS PREPARATION.
NO903438L (en) PROCEDURE FOR THE PREPARATION OF TIAZOLD DERIVATIVES.
NO331002B1 (en) Thioxanthine derivatives and pharmaceutical preparations with thioxanthine derivatives
DK159444C (en) ANALOGY PROCEDURE FOR PREPARING DERIVATIVES OF 9- (2-HYDROXYETHOXYMETHYL) GUANINE
HUT60507A (en) Process for producing trifluoromethyl ketone derivatives and pharmaceutical compositions comprising same as active ingredient
NO971625L (en) Novel peptides with immunomodulatory effects
NO931527L (en) CYCLIC IMINO DERIVATIVES, MEDICINAL PREPARATIONS CONTAINING THESE, AND PROCEDURE FOR THEIR PREPARATION
NO20022123L (en) Oxoxazole derivatives for use as inhibitors of phosphodiesterase VII
FI882002A (en) Process for the preparation of therapeutically active phenylpiperidine derivatives
DK0634396T3 (en) Amino acid derivatives and their use as single phalinase inhibitors
HUT45081A (en) Process for producing amino acid derivatives and pharmaceuticals comprising these compounds as active ingredient
NO940131L (en) Salts of 4-pyrimidinone derivatives for pharmaceutical use
NO982072D0 (en) Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase